Select Page

Critical Reagent Generation

“Off-the-Shelf” antibodies may be quick and easy, but they lack the ability to meet specific needs on a situational basis.

As a biotherapeutic enablement company, our focus is on reagent performance – designing, generating, purifying, characterizing and providing LCM of custom biological reagents suitable for the intended purpose.

Generating pharmaceutical-grade custom biological reagents, controlled storage, comprehensive life-cycle management, and global distribution distinguishes us from conventional reagent companies.

B2S Life Sciences® works with you to develop the right type of reagent for your bioanalytical needs. We create monoclonal, polyclonal and recombinant antibodies to fit your specific bioanalytical need and can even can help design the antigen to produce the final product with high specificity and affinity.

Our extensive expertise in designing custom biological reagents that result in robust assays to support analysis of immunogenicity, PK and clinical biomarker development by utilizing the latest technologies to fully characterize your reagent and uses the most extensive collection of chemistries for conjugation and labeling.


Already Have a Reagent?

B2S Life Sciences® not only generates custom reagents – we can help you manage your own by preparing, characterizing and managing that reagent throughout its life cycle.

Our team of skilled scientists is capable of supporting your custom peptide and protein generation and supply needs. Whether the protein is designed to be a reagent, immunogen, for developing antibodies or reference standard, optimization and design are critical to the quality of the end product.

We utilize modern molecular biology and protein chemistry technologies to provide high-quality proteins and peptides. Our methods are also scalable, resulting in a consistent and continuous supply of products.


Have Your Own Protocol?

B2S Life Sciences® is more than happy to work with you to transfer that method and optimize it for high-quality yields.

Our peptide chemists have decades of experience designing synthetic routes for the most optimal peptide sequence. Our process employs a thorough risk assessment that looks for common and rare challenges to the selected design, as well as back-up routes to ensure an efficient and quality result.